Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC
1 other identifier
observational
170
1 country
1
Brief Summary
This study aims to see if there's a link between a substance called phosphatidylethanol (PEth) and how patients who have surgery at University Hospitals do after surgery. PEth levels reflect the amount of alcohol use by someone over the past few weeks. This study is checking PEth levels on all patients who are planned to stay in the hospital for three or more days after surgery regardless if they drink alcohol. Specifically, it will look at if PEth levels are connected to problems that might come up during and after surgery, like confusion, lung or heart issues, needing blood transfusions, infections, unexpected intensive care unit (ICU) stays, and longer hospital stays. While there are reports of moderate alcohol consumption being good for the heart, there are other data that alcohol consumption can be harmful. Since there's not much information on how drinking alcohol affects health outcomes during and after surgery, especially for patients who are planned to be admitted to the hospital ward or ICU after surgery, this study will hopefully see if PEth levels before surgery can predict how patients do after the surgery. The inclusion criteria to only include patients who consume alcoholic beverages was an IRB approved modification after already recruiting 1/3 of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2025
CompletedFirst Posted
Study publicly available on registry
March 7, 2025
CompletedStudy Start
First participant enrolled
May 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
January 12, 2026
January 1, 2026
1.2 years
March 3, 2025
January 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Phosphatidylethanol level as measured by blood draw.
Baseline
Length of ICU stay measured in days
Up to 7 days
Length of hospital stay measured in days
Up to 2 weeks
Number of perioperative complications as measured by medical record review.
Perioperative complications including but not limited to delirium, pulmonary complications, cardiovascular complications, need for transfusion including amount transfused, post-operative infections, unexpected admission to the intensive care unit (ICU) and increased length of stay
Up to six months
Study Arms (1)
Patients undergoing elective surgery at UHCMC.
Patients will have a single blood sample sent for PEth testing.
Interventions
Patients will have a single blood sample sent for PEth testing, blood draws will happen during standard of care blood draw.
Eligibility Criteria
Patients undergoing elective surgery at UHCMC.
You may qualify if:
- \. Age range: 21-79
- \. Patients undergoing elective surgery at UHCMC with planned ICU admission
- \. Patients undergoing elective surgery at UHCMC with expected in-hospital admission for three or more days
- \. Only patients who consume alcoholic beverages on a regular basis.
You may not qualify if:
- \. Patients undergoing same day outpatient surgeries or expected to be admitted less than three days post-operatively
- \. Subjects who have received a blood transfusion within the past month before surgery
- \. Pregnant subjects
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital
Cleveland, Ohio, 44106, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Salim Hayek, MD, PhD
University Hospitals
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Vice Chair for Clinical Research, Department of Anesthesiology
Study Record Dates
First Submitted
March 3, 2025
First Posted
March 7, 2025
Study Start
May 5, 2025
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
January 12, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share